☆ 4.6 Article

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients

FRONTIERS IN MICROBIOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Medical Laboratory Technology

Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies

Younhee Park et al.

Summary: This study evaluated the clinical performance of SARS-CoV-2 antibody assays available in Korea for seroprevalence studies of COVID-19. The results showed good sensitivity and specificity for several assays, and it was recommended to use a combination of two or more assays to improve the positive predictive value.

ANNALS OF LABORATORY MEDICINE (2022)

Add to Collection

Review Medicine, General & Internal

Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review

David Jarrom et al.

Summary: This systematic review aims to evaluate the clinical effectiveness of tests for diagnosing COVID-19 through the detection of SARS-CoV-2 virus and antibodies. It highlights the uncertainties regarding the effectiveness of these tests and emphasizes the need for further research on disease management and virus testing strategies.

BMJ EVIDENCE-BASED MEDICINE (2022)

Add to Collection

Article Infectious Diseases

High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa

For Yue Tso et al.

Summary: The study found a higher prevalence of SARS-CoV-2 cross-reactive antibodies in pre-pandemic plasma samples from SSA compared to the USA, indicating potential cross-protection due to prior exposure to other coronaviruses in SSA. The detection of nucleocapsid proteins from HCoV-NL63 and HCoV-229E in most samples suggests these viruses as the likely sources of cross-reactive antibodies against SARS-CoV-2. The low incidence of SARS-CoV-2 infection and disease in SSA may be correlated with pre-pandemic serological cross-recognition of HCoVs, which are more prevalent in SSA than the USA.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy

Anna Latiano et al.

Summary: The study evaluated the performance of serological tests using serum samples collected before the outbreak of COVID-19 in 2018 and 2019, highlighting the limited usefulness of serological testing for detecting SARS-CoV-2 virus based on pre-outbreak specimens.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Virology

Potential false-positive reasons for SARS-CoV-2 antibody testing and its solution

Qing Ye et al.

Summary: The false-positive detection of SARS-CoV-2 antibodies in clinical practice is mainly caused by endogenous interference factors like rheumatoid factor and heterophile antibodies, as well as exogenous interference factors including incomplete coagulation of the specimen and contamination of the specimen. These interferences can lead to confusion in the clinical diagnosis of COVID-19.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Immunology

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

Stephan Schlickeiser et al.

Summary: Clinical trials on the use of COVID-19 convalescent plasma have shown inconclusive results, with some patients potentially benefiting from the treatment of convalescent plasma neutralizing antibodies. Studies suggest that COVID-19 patients requiring hospitalization and experiencing fever symptoms may have higher risk of having lower levels of neutralizing antibodies.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Medical Laboratory Technology

Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays

Sojeong Yun et al.

Summary: The study compares antibody responses and seroconversion of COVID-19 patients using different immunoassays, highlighting variability in positivity rates and seroconversion based on assay kits, disease severity, and antigen target. This contributes to a better understanding of the performance and limitations of currently available immunoassays for clinical diagnosis in symptomatic COVID-19 patients.

ANNALS OF LABORATORY MEDICINE (2021)

Add to Collection

Review Medical Laboratory Technology

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories

Y. Victoria Zhang et al.

Summary: This document aims to provide a comprehensive reference for laboratory professionals and healthcare workers to appropriately implement SARS-CoV-2 serologic assays in the clinical laboratory and to interpret test results during this pandemic. It discusses the verification and validation of EUA and LDT assays, along with a quality management approach. Recommendations for serologic testing indications, result interpretation and the role of orthogonal testing are presented.

CLINICAL CHEMISTRY (2021)

Add to Collection

Article Infectious Diseases

Comparison of SARS-CoV-2 IgM and IgG seroconversion pro fi les among hospitalized patients in two US cities

Erika P. Orner et al.

Summary: The study tracked the seroconversion of IgG and IgM antibodies in 89 patients with SARS-CoV-2 infection, finding that about half of the patients developed IgG and IgM antibodies simultaneously, while some patients first developed IgM antibodies before IgG antibodies. Additionally, immunocompromised patients and those under 65 years of age had prolonged time to seroconversion for IgG and IgM.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)

Add to Collection

Article Medical Laboratory Technology

Performance Evaluation of the Siemens SARS-CoV-2 Total Antibody and IgG Antibody Test

Lisa Florin et al.

Summary: This study evaluated the performance of 2 commercially available SARS-CoV-2 antibody assays and found both tests to have acceptable performance. Although Seroconversion occurred earlier with the COV2T test, both tests showed a sensitivity approaching 100% after 14 days of symptom onset.

LABORATORY MEDICINE (2021)

Add to Collection

Review Immunology

Antibody Responses in COVID-19: A Review

Mateo Chvatal-Medina et al.

Summary: The SARS-CoV-2 continues to spread as a severe pandemic, with variable seroprevalence rates worldwide and higher rates among health workers. The cross-neutralizing response between SARS-CoV and SARS-CoV-2 is controversial, and the use of convalescent plasma has shown uncertain results. Cellular immunity plays a crucial role in resolving the infection.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

Suellen Nicholson et al.

Summary: This study evaluated the performance of 6 commercially available ELISAs for SARS-CoV-2 serology testing and found a high consistency in detection of different antibody types. The results demonstrate the reliability and accuracy of SARS-CoV-2 serology testing in detecting the humoral immune response following infection.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Review Immunology

Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control

Seongman Bae et al.

Summary: The key characteristics of COVID-19 transmission include asymptomatic spread, lack of dominant systemic symptoms, high infectious dose for airborne transmission, and super-spread events. These traits make it easy for the virus to spread in the community and highlight the importance of universal mask-wearing to prevent both outward and inward transmission.

IMMUNE NETWORK (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Review Medicine, Research & Experimental

Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2

Sairaj Satarker et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

Add to Collection

Article Immunology

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Wanbo Tai et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Li Guo et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Medical Laboratory Technology

Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity

Thomas Perkmann et al.

CLINICAL CHEMISTRY (2020)

Add to Collection

Article Virology

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

A. J. Jaaskelainen et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Chee Wah Tan et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers

N. Kumleben et al.

PUBLIC HEALTH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay

Carol Ho-Yan Fong et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Virology

SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons

Nele Wellinghausen et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

Dianna L. Ng et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Medical Laboratory Technology

Update on serologic testing in COVID-19

Rafal Krajewski et al.

CLINICA CHIMICA ACTA (2020)

Add to Collection

Article Medicine, General & Internal

IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea

Suk-Kyoon Song et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Add to Collection

Article Immunology

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Baoqing Sun et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Immunology

Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan

Shey-Ying Chen et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.